Comparative metabolism of cyclophosphamide and ifosfamide in the mouse using UPLC–ESI-QTOFMS-based metabolomics
- 1 October 2010
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 80 (7) , 1063-1074
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- National Cancer Institute
- National Cancer Institute
This publication has 67 references indexed in Scilit:
- Xenobiotic Metabolism: A View through the MetabolometerChemical Research in Toxicology, 2010
- Humanized Mouse Lines and Their Application for Prediction of Human Drug Metabolism and Toxicological Risk AssessmentThe Journal of Pharmacology and Experimental Therapeutics, 2008
- Identification of Novel Toxicity-associated Metabolites by Metabolomics and Mass Isotopomer Analysis of Acetaminophen Metabolism in Wild-type and Cyp2e1-null MiceJournal of Biological Chemistry, 2008
- A Metabolomic Perspective of Melatonin Metabolism in the MouseEndocrinology, 2008
- A Comprehensive Investigation of 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) Metabolism in the Mouse Using a Multivariate Data Analysis ApproachChemical Research in Toxicology, 2007
- Urinary Metabolite Profiling Reveals CYP1A2-Mediated Metabolism of NSC686288 (Aminoflavone)The Journal of Pharmacology and Experimental Therapeutics, 2006
- A Metabolomic Approach to the Metabolism of the Areca Nut Alkaloids Arecoline and Arecaidine in the MouseChemical Research in Toxicology, 2006
- Pharmacokinetics, metabolism and clinical effect of ifosfamide in breast cancer patientsEuropean Journal of Cancer, 1995
- Comparison of continuous infusion and bolus administration of ifosfamide in childrenEuropean Journal of Cancer, 1995
- 2-Chloroacetaldehyde, a metabolite of cyclophosphamide in the ratXenobiotica, 1983